Non-Arteritic Ischemic Optic Neuropathy Following COVID-19 Vaccination in Korea: A Case Series
- PMID: 36974402
- PMCID: PMC10042731
- DOI: 10.3346/jkms.2023.38.e95
Non-Arteritic Ischemic Optic Neuropathy Following COVID-19 Vaccination in Korea: A Case Series
Abstract
Background: To report the clinical manifestations of non-arteritic anterior ischemic optic neuropathy (NAION) cases after coronavirus disease 2019 (COVID-19) vaccination in Korea.
Methods: This multicenter retrospective study included patients diagnosed with NAION within 42 days of COVID-19 vaccination. We collected data on vaccinations, demographic features, presence of vascular risk factors, ocular findings, and visual outcomes of patients with NAION.
Results: The study included 16 eyes of 14 patients (6 men, 8 women) with a mean age of 63.5 ± 9.1 (range, 43-77) years. The most common underlying disease was hypertension, accounting for 28.6% of patients with NAION. Seven patients (50.0%) had no vascular risk factors for NAION. The mean time from vaccination to onset was 13.8 ± 14.2 (range, 1-41) days. All 16 eyes had disc swelling at initial presentation, and 3 of them (18.8%) had peripapillary intraretinal and/or subretinal fluid with severe disc swelling. Peripapillary hemorrhage was found in 50% of the patients, and one (6.3%) patient had peripapillary cotton-wool spots. In eight fellow eyes for which we were able to review the fundus photographs, the horizontal cup/disc ratio was less than 0.25 in four eyes (50.0%). The mean visual acuity was logMAR 0.6 ± 0.7 at the initial presentation and logMAR 0.7 ± 0.8 at the final visit.
Conclusion: Only 64% of patients with NAION after COVID-19 vaccination have known vascular and ocular risk factors relevant to ischemic optic neuropathy. This suggests that COVID-19 vaccination may increase the risk of NAION. However, overall clinical features and visual outcomes of the NAION patients after COVID-19 vaccination were similar to those of typical NAION.
Keywords: Coronavirus Disease 2019 (COVID-19); Non-Arteritic Anterior Ischemic Optic Neuropathy; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); Vaccination.
© 2023 The Korean Academy of Medical Sciences.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures


Similar articles
-
[Optic nerve morphology and vessel density in eyes with different phases of non-arteritic anterior ischemic optic neuropathy].Zhonghua Yan Ke Za Zhi. 2019 Sep 11;55(9):677-686. doi: 10.3760/cma.j.issn.0412-4081.2019.09.010. Zhonghua Yan Ke Za Zhi. 2019. PMID: 31495153 Chinese.
-
Comparison of peripapillary retinal nerve fiber layer loss and visual outcome in fellow eyes following sequential bilateral non-arteritic anterior ischemic optic neuropathy.Curr Eye Res. 2015 May;40(6):632-7. doi: 10.3109/02713683.2014.952829. Epub 2014 Aug 25. Curr Eye Res. 2015. PMID: 25153943
-
Assessment of peripapillary vessel density in acute non-arteritic anterior ischemic optic neuropathy.Int Ophthalmol. 2020 May;40(5):1269-1276. doi: 10.1007/s10792-020-01293-9. Epub 2020 Jan 20. Int Ophthalmol. 2020. PMID: 31960199
-
Optic neuropathies post-Covid 19 - review.Rom J Ophthalmol. 2022 Oct-Dec;66(4):289-298. doi: 10.22336/rjo.2022.54. Rom J Ophthalmol. 2022. PMID: 36589322 Free PMC article. Review.
-
NAION or not NAION? A literature review of pathogenesis and differential diagnosis of anterior ischaemic optic neuropathies.Eye (Lond). 2024 Feb;38(3):418-425. doi: 10.1038/s41433-023-02716-4. Epub 2023 Sep 28. Eye (Lond). 2024. PMID: 37770527 Free PMC article. Review.
Cited by
-
Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review.Front Immunol. 2025 Feb 4;16:1515768. doi: 10.3389/fimmu.2025.1515768. eCollection 2025. Front Immunol. 2025. PMID: 39967658 Free PMC article. Review.
-
Prevalence and Distribution of Macular Fluid with Central Retinal Artery Occlusion and Anterior Ischemic Optic Neuropathy.Clin Ophthalmol. 2024 Mar 21;18:887-893. doi: 10.2147/OPTH.S457503. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38529006 Free PMC article.
-
Cranial neuropathy following coronavirus disease 2019 vaccination in kidney transplant recipients.IJU Case Rep. 2024 Oct 2;7(6):423-426. doi: 10.1002/iju5.12761. eCollection 2024 Nov. IJU Case Rep. 2024. PMID: 39498178 Free PMC article.
References
-
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous